How USAID Programs Use Digital Health Screening Technology

USAID digital health screening technology investments have shaped the trajectory of global health informatics over the past fifteen years, evolving from small innovation grants into a strategic pillar of the agency's development programming. Between 2020 and 2025, USAID allocated over $340 million to digital health activities across its operating units, with screening technology — tools that identify health conditions at the community or primary care level — representing the fastest-growing investment category. This analysis maps how these investments translate into field-level programs and examines the evidence base guiding future funding decisions.

"Digital health is no longer an experiment at USAID. It is a core delivery mechanism for achieving epidemic control, reducing maternal mortality, and building resilient health systems. Our investments must now focus on sustainability and country ownership." — USAID Digital Strategy 2024–2028

Analysis of USAID's Digital Health Screening Portfolio

USAID's digital health screening investments operate through multiple funding mechanisms with distinct models, timelines, and evidence requirements. The agency's approach shifted markedly with the USAID Digital Health Vision (2020), which established interoperability, country ownership, and evidence-based investment as the three organizing principles. Screening programs are now evaluated against these principles at every funding stage.

Comparison of USAID Digital Health Screening Funding Mechanisms

Dimension	PEPFAR Country Operational Plans	Global Health Bureau Awards	DIV (Development Innovation Ventures)	Bureau for Humanitarian Assistance
Funding Scale	$5M–$50M per country per year	$2M–$20M per award	$100K–$15M (staged)	$1M–$30M per response
Timeline	Annual planning cycle (COP)	3–5 year awards	Stage 1: 1–2 yr; Stage 2: 2–3 yr; Stage 3: 3–5 yr	Rapid deployment (weeks)
Screening Focus	HIV testing, TB case finding, viral load	Maternal health, NCDs, malaria	Emerging technologies (AI, rPPG, point-of-care)	Outbreak detection, malnutrition, trauma triage
Technology Maturity	Proven at scale	Evidence-based, approaching scale	Early-stage through proven	Rapid-deploy, field-hardened
Country Ownership Requirement	High — integrated into national systems	High — MoH engagement required	Low initially; increasing with stage	Variable — emergency context dependent
Evidence Standard	Programmatic data + quarterly reporting	Rigorous evaluation (often RCT)	Staged evidence generation	Operational effectiveness
Key Implementing Partners	Large IPs (FHI 360, JSI, Jhpiego, ICAP)	Mix of academic and implementing partners	Innovators, social enterprises, startups	INGOs, UN agencies

The most significant structural change is the integration of screening technology into core program budgets. A review of FY2024–2025 Country Operational Plans reveals that 78% of PEPFAR-supported countries now include digital screening as line items within clinical service delivery budgets, up from 31% in FY2020 (PEPFAR Panorama, 2025).

Applications Across USAID Health Portfolios

PEPFAR and Epidemic Control

PEPFAR's use of digital screening technology is concentrated in three areas: HIV testing services (HTS) optimization, index testing facilitation, and differentiated service delivery.

The HIV Self-Testing (HIVST) digital support programs represent PEPFAR's most scaled digital screening investment. Across 15 priority countries, smartphone-based applications guide users through self-testing procedures and connect reactive testers to confirmatory testing. A multi-country evaluation in PLOS Medicine (Johnson et al., 2023) found that digitally supported HIVST achieved linkage-to-care rates of 74%, compared to 58% for unsupported distribution.

In index testing, the USAID-funded RISE initiative in Southern Africa deployed tablet-based screening applications that guide health workers through risk assessment protocols. This workflow increased contacts elicited per index client from 1.8 to 3.2 and raised HIV positivity among tested contacts from 12% to 19%, indicating more effective targeting (RISE Quarterly Report, Q2 2025).

Maternal and Child Health

USAID's maternal health portfolio has embraced digital screening as a mechanism for extending antenatal and postnatal care into communities. The flagship investment in this space is the MOMENTUM suite of awards, which collectively represent over $1 billion in maternal, newborn, and child health programming across 35 countries.

Within MOMENTUM, digital screening serves two functions. Community-based tools enable CHWs to identify high-risk pregnancies during home visits — a nested evaluation in India demonstrated that digital screening identified 91% of women meeting WHO high-risk criteria, compared to 64% through standard clinical assessment (MOMENTUM Annual Report, 2024). Facility-based digital triage systems use vital signs data to classify patients by acuity and route them to appropriate care pathways.

Non-Communicable Diseases

USAID's NCD programming has expanded rapidly since 2022, driven by recognition that NCDs account for 74% of global deaths and disproportionately impact LMICs. The USAID-funded Resolve to Save Lives partnership has deployed digital hypertension screening protocols in 32 countries, reaching an estimated 8 million individuals through community-based blood pressure measurement programs (Resolve to Save Lives, 2025). The digital infrastructure — which standardizes measurement protocols, automates risk classification, and triggers referral for confirmed hypertensives — has been integrated into national NCD programs in 14 countries.

An emerging area is integrated multi-disease screening, where a single digital encounter captures data points relevant to multiple conditions. A USAID-funded pilot in Tanzania combined hypertension screening, diabetes risk assessment, and cardiovascular risk scoring into a five-minute digital workflow administered by CHWs. The pilot found that 34% of individuals identified as high-risk for hypertension also screened positive for elevated diabetes risk, demonstrating the efficiency gains of integrated digital screening over vertical approaches (PATH, 2024).

Research Informing USAID Investment Decisions

Several bodies of research are actively shaping how USAID allocates resources to digital health screening technology.

Cost-effectiveness evidence. A systematic review commissioned by the USAID Bureau for Global Health (Hutchinson et al., 2024, Health Policy and Planning) analyzed 38 digital screening programs across 16 countries. The median ICER for digital versus paper-based screening was $42 per additional case detected for hypertension, $187 for HIV, and $23 for maternal risk — all below WHO willingness-to-pay thresholds.

Equity impacts. A multi-site study across Kenya, Malawi, and Mozambique found that digitally enabled community screening reached 2.3 times more individuals in the lowest wealth quintile compared to facility-based screening alone (Geldsetzer et al., 2023, Nature Medicine). Digital tools enabled screening in communities distant from facilities, where the poorest populations concentrate.

Artificial intelligence integration. USAID's Development Innovation Ventures program has funded several AI-enhanced screening technologies, including computer vision for pediatric malnutrition screening, machine learning for TB screening from chest X-rays, and remote photoplethysmography (rPPG) for contactless vital signs estimation. The agency's position, articulated in the USAID Artificial Intelligence Action Plan (2024), is that AI-enhanced screening must demonstrate performance across diverse populations before scaling, with attention to bias detection and mitigation.

Future Directions for USAID Digital Health Screening

Transition to country-owned platforms. The most consequential policy shift is USAID's requirement that all new digital health investments include explicit country ownership transition plans. By FY2027, programs must demonstrate a pathway to domestic financing and government technical management within the award period. Open-source platforms with government hosting capability are increasingly favored over proprietary solutions.

Contactless screening technologies. USAID's interest in camera-based physiological measurement reflects a broader strategic goal of reducing hardware dependency in community health programs. Smartphone-based estimation of vital signs through rPPG technology could enable screening at a fraction of current device costs while leveraging the smartphone infrastructure that already exists in most LMIC health worker cadres. The agency's 2025 Annual Program Statement for digital health innovation specifically identified contactless vital signs as a priority technology area.

Real-world evidence platforms. USAID is investing in health information infrastructure that can generate continuous evidence from routine program data. The agency's support for the OpenHIE framework and FHIR-based interoperability standards is creating data pipelines that connect community screening platforms to national health information systems, enabling real-time monitoring of screening coverage, yield rates, and linkage to care at population scale.

FAQ

How much does USAID spend on digital health screening annually?

USAID's total digital health spending was approximately $68 million in FY2025, with screening representing roughly 40% ($27 million). Including digital screening tools embedded within larger awards (particularly PEPFAR COPs), the effective annual investment likely exceeds $80 million.

What technology standards does USAID require for digital health screening programs?

USAID requires alignment with the Principles for Digital Development, interoperability with national health information systems (preferably HL7 FHIR), host-country-compliant data security, and open-source or open-architecture design. Since 2023, all new awards must include a Technology Sustainability Assessment evaluating long-term maintainability and country ownership feasibility.

How does USAID evaluate whether a digital screening technology is ready for scale?

Technologies must demonstrate effectiveness from at least two rigorous LMIC evaluations, operation at 500+ health workers or 50,000+ individuals screened, integration with a national health information system, and a defined total cost of ownership model with a domestic financing pathway. The DIV staged funding mechanism supports technologies through this maturation.

Which USAID programs are exploring camera-based or contactless screening?

The DIV portfolio includes rPPG-based vital signs investments for community health. The MOMENTUM awards are piloting camera-based screening for antenatal care in India and East Africa. PEPFAR's Science and Technology Advisor has identified contactless screening as a priority for COP26. The common thread is reducing hardware dependency while maintaining screening effectiveness.

How can organizations align their technology with USAID funding priorities?

Monitor Annual Program Statements and Broad Agency Announcements through SAM.gov and the USAID Business Forecast. Technologies demonstrating FHIR-based interoperability, country ownership readiness (open-source, government-hostable), and evidence of LMIC effectiveness are most competitive. Engaging with USAID's Digital Health team through public consultations provides insight into evolving priorities.

---

For a deeper look at how camera-based vital signs estimation is emerging as a screening tool within global health programs, visit our research hub for technical analysis and implementation evidence.